VKTX
USDViking Therapeutics Inc. Common Stock
Цена в режиме реального времени
График цен
Ключевые показатели
Рыночные показатели
Открытие
$36.740
Максимум
$38.000
Минимум
$34.615
Объем
3.77M
Фундаментальные показатели компании
Рыночная капитализация
3.9B
Отрасль
Биотехнология
Страна
United States
Статистические данные торговли
Средний объем
6.60M
Биржа
NCM
Валюта
USD
52-недельный диапазон
Связанные новости
Metsera the US obesity biotech at centre of Novo, Pfizer bidding war
Metsera has become the obesity drug market's hottest ticket.
Canaccord Genuity Initiates Coverage On Viking Therapeutics with Buy Rating, Announces Price Target of $106
Canaccord Genuity analyst Edward Nash initiates coverage on Viking Therapeutics with a Buy rating and announces Price Target of $106.
JP Morgan Maintains Overweight on Viking Therapeutics, Lowers Price Target to $75
JP Morgan analyst Hardik Parikh maintains Viking Therapeutics with a Overweight and lowers the price target from $80 to $75.
Morgan Stanley Maintains Overweight on Viking Therapeutics, Raises Price Target to $102
Morgan Stanley analyst Michael Ulz maintains Viking Therapeutics with a Overweight and raises the price target from $98 to $102.
Viking Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Viking Therapeutics, Inc. (Viking) (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...
Viking Therapeutics Announces Initiation of VK2735 Maintenance Dosing Clinical Trial in Patients with Obesity
Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for...
Связанные акции
Оставаться в курсе
Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.